Senior Director, Quantitative & Clinical Pharmacology
Sarepta Therapeutics · Virginia, United States · 1 wk ago
HybridAnalyst$222k–$278k/yrFull-time
The Importance of the Role
This leadership role will be developing and executing translational, clinical pharmacology and pharmacometrics strategies and deliverables from early through late-stage clinical development. Key areas of emphasis will include but are not limited to clinical dose selection and refinement across all phases of clinical development, FIH and clinical pharmacology study designs, development and hands-on application of MIDD using population and statistically based methodologies, as well as mechanistic and translational PK/PD approaches.
This role will manage a team of scientists and serve as a SME on programs.
Key Areas of Emphasis
- Develop and execute translational and mechanistically based PK/PD modeling to enable identification of FIH dose, early characterization of efficacy and safety using biomarkers and disease animal models
- Lead and execute pharmacometrics strategies across all stages of drug development including population PK, PK/PD modeling and simulations, meta-analysis, disease modeling to inform clinical development
- Support non-clinical PK/PD, ADME and DMPK evaluations including strategy development, study design and execution, data analyses to inform lead optimization, candidate selection and nonclinical drug development
- Represent as functional lead for global regulatory activities and HA engagements (NDA and/or BLA experience is a must)
The Opportunity to Make a Difference
- Lead clinical pharmacology and pharmacometrics workstreams in CNS diseases (rare disease drug development experience preferred)
- Represent as therapeutic lead (siRNA or oligonucleotide experience is preferred) and SME in clinical pharmacology strategies, clinical study protocol preparation, study execution, data review/analysis, and study reports
- Lead the development and execution of translational and mechanistically based PK/PD modeling to enable identification of FIH dose, early characterization of efficacy and safety using biomarkers and disease animal models
- Supervise, mentor and develop a team of high-performing scientists
- Contribute to platform-based pharmacology activities across novel genetic modalities and disease indications
- Encompass leading-edge knowledge in clinical pharmacology and pharmacometrics discipline, publish manuscripts
- Advocate scientific leadership at external conferences and scientific community